 |
News
Latest hi-tech news from the region |
|
|
|
|
|
|
|
|
|
|
Finance
|
|
|
| | Nikon Metrology to deliver the most powerful industrial microfocus CT system in North-America to Chesapeake Testing | 7/9 | Nikon Metrology announces that Chesapeake Testing has ordered a combined 225-450kV microfocus X-ray and computer tomography (CT) system. Chesapeake Testing primarily selected this powerful inspection system for its highly accurate 450kV source, the only microfocus X-ray source at this energy. The system's powerful source, walk-in bay and Panel Shift capability allow Chesapeake Testing to scan large objects up to 39' wide made of dense materials such as metals, ceramics and composites. The system  | | |
| | | | | Option reports First Half Year 2010 results | 31/8 | | Leuven, Belgium - August 31, 2010 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results for the first half fiscal year ended June 30, 2010. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union. The accounting policies and methods of computation followed in the attached financial statements are | | |
| | | TiGenix announces spin-out of its targeted drug discovery activities in newco Arcarios | 26/8 | | Leuven (BELGIUM) - August 25, 2010 - TiGenix (NYSE EURONEXT: TIG) has entered into an agreement with its academic partners, the Catholic University Leuven (KULeuven) and Ghent University(UGent), the Dutch company Therosteon and a consortium of investors for the creation of a new small molecule drug development company, Arcarios, that will focus on the discovery and development of innovative, disease modifying drugs that target bone and joint diseases. TiGenix has a significant equity stake in | | |
| | | Steunplafond KMO-Portfeuille verlaagd voor de pijler advies | 25/8 | | Het kabinet van Kris Peeters, Vlaams minister voor Economie, Buitenlands Beleid, Landbouw en Plattelandsbeleid, deelt mee dat sinds de invoering van het systeem van de kmo-portefeuille op 1 januari 2009 het aantal aanvragen voor de pijler advies exponentieel gestegen is. Hierdoor dreigt het voorziene budget vroegtijdig opgebruikt te worden. Om dit probleem te voorkomen heeft de minister beslist het steunplafond van de pijler advies te verlagen van maximaal 5.000 euro per jaar naar maximaal 2.500 | | |
| | | Transparency Information | 27/7 | Leuven (BELGIUM) - July 23, 2010 - TiGenix (NYSE EURONEXT BRUSSELS: TIG)publishes the information in accordance with articles 15, 18 and 29 of the Belgian Act of May 2, 2007 and the Royal Decree of February 14, 2008, regarding the publication of major holdings in issuers whose securities are admitted to trading on a regulated Belgian market.
TiGenix has received a notification with regard to the participation in TiGenix NV of F&C Asset Management Ltd, having its registered office at 80 George | | |
| | | Deloitte Technology Fast50 competition | 1/7 | Election of the 50 fastest growing technology companies
Deadline for registration: 1 August 2010.
Online registration is now available
For the eleventh year Deloitte and its co-sponsors organise the Deloitte Technology Fast50.
Participants can be public or private, and encompass all technology industry segments including software, internet, biotech/pharmaceutical/medical equipment, computers/peripherals, semiconductors/components/electronics, telecommunications/networking, | | |
| | | ABLYNX AND REMYND SETTLE DISPUTE AMICABLY | 2/6  | GHENT and LEUVEN, Belgium, 2 June 2010 - Ablynx NV [Euronext Brussels: ABLX] and reMYND NV announced today that they have reached a settlement concerning a dispute relating to a collaboration agreement to discover and commercialize new Nanobodies® which Ablynx and reMYND entered into in 2003.
In 2007, Ablynx was notified by reMYND that a difference of interpretation existed in respect of Ablynx's contractual obligation to reMYND under the 2003 agreement. Under this agreement, Ablynx had the | | |
| | | TiGenix Business and Financial Update for the First Quarter of 2010 | 25/5 | Leuven (BELGIUM) - May 19, 2010 - TiGenix (NYSE EURONEXT: TIG) gives a business and financial update as of March 31, 2010.
Business Update
Commercial roll-out of ChondroCelect® in Europe
During the first quarter of 2010, TiGenix has begun the commercial launch of its lead product, ChondroCelect, in Germany, Belgium, the United Kingdom and the Netherlands.
While working towards reimbursement in our key target markets, the first 'prereimbursement' ChondroCelect patients have been treated | | |
| | | Imec successfully concludes 2009 thanks to strengthened global open innovation | 4/5 | | Leuven, Belgium - April 30 2010 - At today's General Assembly, the imec Board announced the results of 2009. Despite the severe economical downturn, 2009 was a satisfying year for imec. Imec's total revenue amounted to 275 million euro, including 222 million euro coming from collaboration with the global industry. 44.7 million euro was granted to imec Belgium by the Flemish government, to guarantee imec's long term research and investment in new research initiatives, and imec the Netherlands at | | |
| | | AnSem announces profit in 2009 | 3/5 | During the Annual General Meeting held on April 20, 2010, AnSem's shareholders have approved the results of the fiscal year 2009. AnSem is pleased to announce that the company ended once more the fiscal year with a positive result. This sets AnSem's track record of profitability to the 12th year in a row and confirms AnSem's dedication to be a stable and solid partner to its customers.
'Although the economy has been challenging in 2009, AnSem has been able to finish the year with a | | |
| | | Option trading update - first quarter 2010 | 29/4 | LEUVEN, Belgium - April 29, 2010 - Option (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced that during the first quarter of 2010 the Company generated revenue of EUR 13.1 million. The continuing pressure of Chinese competition on the commoditized USB modem market in particular explains the continuing market share losses, stressing the need for the product repositioning strategy currently underway.
Cost savings are on track with cash operating expenses | | |
| | | Punch Powertrain secures 24 million euro capital | 6/4 | Leuven, Belgium: 31 March 2010 - Gimv and Capricorn supply additional funding for the further development and commercialisation of Punch Powertrain's CVT drivetrains
Punch Powertrain www.punchpowertrain.com is an independent manufacturer of Continuously Variable Transmission systems (CVTs) for cars. The company was acquired by Punch International in 2006. In May 2009, LRM carried out a capital increase of 7 million euro and obtained 30% of the shares in return. Recently, LRM exercised its | | |
| | | AnSem awarded Trends Gazelles 2010 | 26/3 | On March 17th 2010, Trends announced the Trends Gazelles 2010 for the province of Flemish Brabant (Belgium).
AnSem obtained the 6th position in the category of small-sized companies.
Trends is a leading Belgian financial and business newsmagazine. As a Trends Gazelle, AnSem belongs to the fastest growing companies that significantly contribute to the economic dynamism of the region, in terms of employment, innovation, competitiveness and creative entrepreneurship. | | |
| | | Tigenix: Transparency information | 8/3 | Leuven (BELGIUM) - March 8, 2010 - TiGenix (NYSE EURONEXT BRUSSELS: TIG) publishes information in accordance with articles 15, 18 and 29 of the Belgian Act of May 2, 2007 and the Royal Decree of February 14, 2008, regarding the publication of major holdings in issuers whose securities are admitted to trading on a regulated Belgian market.
TiGenix has received a notification with regard to the participation in TiGenix NV of F&C Asset Management Ltd, having its registered office at 80 George | | |
| | | Option reports Fourth Quarter and Full Year 2009 results | 4/3 |
Leuven, Belgium - March 4, 2010 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results for the full fiscal year and fourth quarter ended December 31, 2009. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union. The accounting policies and methods of computation followed in the attached financial | | |
| | | ASML RECEIVES INTEL'S PREFERRED QUALITY SUPPLIER AWARD | 4/3 | VELDHOVEN, Netherlands, March 3, 2010 - ASML has been recognized as one of 16 suppliers to receive Intel Corporation's Preferred Quality Supplier (PQS) award for their performance in 2009. ASML is recognized for their significant contributions, providing Intel with lithography process tools, deemed essential to Intel's success.
'ASML is honored to be selected by Intel as a recipient of their Preferred Quality Supplier award for 2009. This recognition validates a significant mutual effort | | |
| | | Option elects Olivier Lefebvre as new Chairman of the Board of Directors | 22/2 | Philippe Rogge stepping down as COO
LEUVEN, Belgium - February 22, 2010 - Option (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced that Olivier Lefebvre has been appointed as Chairman of the Board of Directors effective immediately. Jan Callewaert will focus full time on his responsibilities as CEO while continuing to serve as a member of the Board of Directors.
Olivier Lefebvre, who has been an Option Board member since July 2008, was previously | | |
| | | Tigenix: Transparency Information | 12/2 | Leuven (BELGIUM) - February 12, 2010 - TiGenix (NYSE EURONEXT BRUSSELS: TIG) publishes the information in accordance with articles 15, 18 and 29 of the Belgian Act of May 2, 2007 and the Royal Decree of February 14, 2008, regarding the publication of major holdings in issuers whose securities are admitted to trading on a regulated Belgian market.
TiGenix has received a notification with regard to the participation in TiGenix NV of ING Group NV, having its registered office at Amstelveenseweg | | |
| | | Laatste fase private plaatsing 3WIN | 12/1 | 3WIN heeft de eerste fase van de plaatsing van converteerbare obligaties vlak voor Kerst succesvol afgerond.
De plaatsing die tot eind januari doorloopt wordt begeleid door Merit Capital.
Ruim EUR 1,6 M euro aan extra middelen is hiermee reeds verzekerd. Met deze eerste som op de rekening en ander
recent goed nieuws loopt ook de tweede fase
Laatste fase private plaatsing 3WIN momenteel veelbelovend.
Deze kapitaalsinjectie maakt het mogelijk voor 3WIN om in 2010 een eerste geavanceerde | | |
| | | ICsense reports a 33% growth | 11/1 | Nov 2009 - ICsense, a leading design house in mixed-signal and high-voltage IC design, has closed its financial year (July 2008 - June 2009). Despite the economical downturn ICsense managed to establish a turnover growth of 33%. For the fifth year in a row, ICsense reports positive results with a positive cash flow.
'The last year has been an important one for ICsense,' says Bram De Muer, CEO of ICsense, 'We grew while the automotive IC design, that was 30% of our business, declined | | |
| | | reMYND versterkt zijn cash reserve | 7/1 | Leuven, België - januari 2010
reMYND NV ('reMYND') heeft een kapitaalsronde afgerond ten einde haar cash reserve verder te verhogen. In totaal werd EUR 1.5 miljoen opgehaald bij Fortis Private Equity Arkimedes NV, Blue
Medical Investments SCA en het Gemma-Frisius Fonds. De eerste 2 partijen zijn nieuwe investeerders, waardoor de aandeelhoudersstructuur van de vennootschap verder werd versterkt.
Over de laatste maanden is reMYND begonnen aan een belangrijke stap voorwaarts: het verst | | |
| | | OPTION REQUESTS SUSPENSION OF TRADING OF SHARES | 18/12 | NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
LEUVEN, Belgium - December 18, 2009 - Option NV announces that it has requested the temporarily suspension of the trading of its shares on Euronext Brussels until the end
of the scrip private placement which will take place today, Friday 18 December 2009, within the framework of its rights offering. Trading in the shares will resume after the
results of the placement are announced.
CONTACT
JP Ziegler, CFO
| | |
| | | Tigenix: Transparency Information | 17/12 | Leuven (BELGIUM) - December 16, 2009 - TiGenix (NYSE EURONEXT BRUSSELS: TIG) publishes the information in accordance with articles 15, 18 and 29 of the Belgian Act of May 2, 2007 and the Royal Decree of February 14, 2008, regarding the publication of
major holdings in issuers whose securities are admitted to trading on a regulated Belgian market.
Further to the closing of the acquisition of Orthomimetics Ltd. announced on December 1, 2009 and the capital increase announced on December 10, 2009 | | |
| | | TiGenix successfully completes private placement raising EUR 7.7million | 11/12 | Leuven (BELGIUM) - December 10, 2009 - TiGenix NV (NYSE Euronext Brussels: TIG) announces that it has successfully raised EUR 7.7 million through a private placement.
Today, TiGenix completed the private placement of EUR 7.7 million with Belgian and international institutional and professional investors in the European Economic Area and
Switzerland through the issuance of 2,204,300 shares at an issuance price of EUR 3.5.
The proceeds will be used to fund TiGenix' commercial launch of | | |
| | | Option is offering 41,249,296 new shares at a subscription price of EUR 0.49 per new share | 10/12 | - Rights issue for an amount of up to EUR 20.2m
- Subscription price: EUR 0.49 per new share Option representing a discount of approximately 47.31% compared to the theoretical price after separation of the Right
- Subscription price represents a discount of 64.23% compared to the closing price on Wednesday December 9th, 2009
- 1 Right gives the right to subscribe to 1 new share
- Coupon nr. 1 was separated on 9 December 2009 after closing of the stock exchange
- Subscription period: 10 | | |
| | | TiGenix announces private placement | 10/12 | REGULATED INFORMATION 10 DECEMBER 2009
Leuven (BELGIUM) - December 10, 2009 - TiGenix NV (NYSE Euronext Brussels: TIG) announces its intention to raise an indicative amount of EUR 7.5 million in a private placement. The proceeds will be used to fund TiGenix' commercial launch of ChondroCelect and ChondroMimetic and to accelerate the clinical pipeline development.
TiGenix intends to raise an indicative amount of EUR 7.5 million. The new shares will be offered through an accelerated | | |
| | | Option announces commitment of Gimv to its rights issue | 9/12 | LEUVEN, Belgium - December 9, 2009 - Option, the wireless technology company, announces that Gimv NV commits itself to support Option's rights issue subject to certain conditions.
Gimv has committed to subscribe to the capital increase for an amount of EUR 2.5 million, in case and to the extent that not all unexercised rights would be sold in the private placement following the rights subscription period. The commitment of Gimv is subject to the Company raising at least EUR 8.5 million | | |
| | | Essensium N.V., an IMEC spin-off, joins the Wavenis Open Standard Alliance and starts volume production of Coronis first Wavenis compliant SOC | 8/12 | Leuven, Belgium, December 8, 2009 - Essensium N.V., a fabless provider of low power System-on-Chip (SOC) solutions, today announced it has joined the Wavenis Open Standard Alliance (Wavenis-OSA), as a Participating Member, enabling them to positively influence the voting committees as the first semiconductor member, all the while continuing its partnership with Coronis S.A.S. to complete Coronis´ first Wavenis compliant SOC.
Wavenis is a leading edge wireless technology platform that was | | |
| | | LSP's portfolio company Movetis raises targeted EUR 85 million in successful Initial Public Offering on Euronext Brussels | 7/12 | First significant size IPO in the European Life Sciences sector since early 2008 -Largest IPO in the Life Sciences sector on Euronext Brussels
Amsterdam, December 4th, 2009
LSP (Life Sciences Partners) today announced that Movetis, a European specialty pharmaceutical company focused on the discovery, development and commercialisation of proprietary, innovative and differentiated drugs for the treatment of diseases in the GI area with a high unmet medical need, has successfully completed | | |
| | | Option indicates preliminary Q4 and full year 2009 results | 2/12 | LEUVEN, Belgium - December 2, 2009 - Option N.V. (Euronext: OPTI; OTC: OPNVY), the wireless technology company, today announced that revenues for the fourth quarter of fiscal year 2009 are expected to be in the range of EUR 20-25 million. These revenues combined with EUR 128 million for the first three quarters of 2009 will generate full year revenue in the range of EUR 148-153 million which is approximately 44% less than the full year 2008.
During the quarter a number of factors affected the | | |
| | | TiGenix closes Orthomimetics acquisition | 1/12 | Leuven (BELGIUM) - December 1, 2009 - TiGenix announces the successful closing of the acquisition of Orthomimetics Limited, a privately held medical technology company based in Cambridge, the United Kingdom.
Further to the press release of 16th November, TiGenix now announces that it has acquired all of the 3,286,438 shares in Orthomimetics at a value of EUR 16,262,338.
The shareholders of Orthomimetics Limited have contributed 2,605,752 Orthomimetics shares, valued at 12.9 million to | | |
| | | OPTION announces rights issue | 1/12 | LEUVEN, Belgium - November 30, 2009 - Option today announces its intention to raise approximately EUR 20 million, by way of a public market transaction with nonstatutory preferential rights to existing shareholders. It is expected that the subscription
period will start on or about December 7th.
The rights are expected to be tradable on Euronext Brussels. The detailed terms and conditions of the transaction will be announced in due time.
Jan Callewaert, both personally and through his | | |
| | | OPTION: FINANCIAL NOTIFICATION | 24/11 | LEUVEN, Belgium - November 23, 2009 - Option today presented in more detail its strategy during an Analyst Briefing. During the meeting the Company reiterated its
strategy to move towards integrated hardware, software and services solutions. In addition, the Company confirms indicating that its targeted revenues for 2010 will be
approximately 20% higher compared to 2009. Finally the Company reconfirmed its previously announced intention to raise approximately EUR20 million in a capital raise
| | |
| | | TiGenix comments on rumors of a capital increase | 6/11 | Regulated information November 5, 2009
Leuven (BELGIUM) - November 5, 2009 - TiGenix comments on reports in the Flemish media regarding a potential capital increase.
With a cash position of 21.9 million EUR on September 30 2009, TiGenix has sufficient financial means at its disposal to finance its activities at least over the coming 12 months, not accounting the expected income generated by sales of ChondroCelect®.
TiGenix has the ambition to become an international player in the | | |
| | | LSP participates in ? 36 Million (US$ 54 Million) Series B Financing of Probiodrug AG | 5/11 | Amsterdam, November 5th, 2009
LSP (Life Sciences Partners) today announced that it has participated in a ? 36 million Series B financing round of Probiodrug AG, Halle/Saale (Germany). Probiodrug is a biotech company developing novel concepts and products for the treatment of neurodegenerative and inflammatory diseases with a special focus on Alzheimers disease.
LSP invested alongside BB Biotech, Edmond de Rothschild Investment Partners (EdRIP) and Biogen Idec New Ventures, all joining as | | |
| | | TiGenix - Business and Financial Update for the Third Quarter of 2009 | 4/11 | Leuven (BELGIUM) - November 3, 2009 - TiGenix (NYSE EURONEXT: TIG) gives a business update and reports cash position as of September 30, 2009.
Business Update
European approval of ChondroCelect®
On October 5, ChondroCelect received the awaited European marketing authorisation from the European Commission and became the first centrally approved Advanced Therapy Medicinal Product in Europe. The approval authorises TiGenix to commercialise the product in the 27 countries of the European | | |
| | | | | Option reports Third Quarter 2009 results, planned capital increase and additional cost reductions | 29/10 | | Leuven, Belgium - October 29, 2009 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announces its results for the third quarter ended 30 September 2009. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union. The accounting policies and methods of computation followed in the attached financial statements are the | | |
| | | Capricorn Venture Partners expands its senior team and launches Capricorn Health-tech Fund | 21/10 | Leuven, Belgium: 21 October 2009 - Capricorn Venture Partners is pleased to announce the launch of its Capricorn Health-tech Fund (CHF).
The objective is to raise Eur 100 to Eur 120 million venture capital for a new fund focusing on early to mid stage human health-technology investments in Europe. Capricorn Venture Partners defines health-technology investments as investments in companies whose business and products relate to the prevention, the diagnosis or the treatment of diseases. The | | |
| | | Biocartis raises 10 million euro in Series A financing round | 15/10 | Lausanne, Switzerland, October 15th 2009 - Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round. The Company raised EUR 10 million (~ USD 14.9 million) from a syndicate of leading life science investors.
The deal was led by Aescap Venture (Amsterdam, The Netherlands). Other members of the syndicate are Biovest | | |
| | | ThromboGenics Raises EUR 0.6 Million from the Exercise of Warrants | 13/10 | Leuven, Belgium - October 9, 2009 - ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, today announces that it has raised EUR 0.6 million as the result of the exercise of warrants by a number of the Company's employees. The 90.000 shares created as a result of this warrant exercise are now listed on Euronext Brussels. Following this
transaction, ThromboGenics now has 26.417.789 shares outstanding. | | |
| | | ASML announces appointment of new COO to the Board of Management | 24/9 | | VELDHOVEN, the Netherlands, September 24, 2009 - ASML Holding NV (ASML) today announces that the Supervisory Board intends to appoint Frederic Schneider-Maunoury as Executive Vice President and Chief Operating Officer (COO) to the Board of Management, subject to notification of the general meeting of shareholders which is scheduled to be held on March 24, 2010. Mr. Schneider-Maunoury (47) is currently Vice President Thermal Products Manufacturing at French industrial and transport equipment | | |
| | | 3WIN : private plaatsing van 5 mio euro | 27/8 | 3WIN : private plaatsing van 5 mio euro voor de verdere ontwikkeling van actieve implanteerbare neurostimulatoren.
3WIN (www.3win.be) werkt op dit ogenblik aan een volledig implanteerbare diepe hersenstimulator (DBS) en een hybride hoorimplant (HAI) op basis van één platform.
Ter financiering van de huidige ontwikkelingen geeft 3WIN een private plaatsing uit van 5 mio euro onder de vorm van een converteerbare obligatielening (zie http://www.meritcapital.be/index.php?itemno=39 ) waarop U kan | | |
| | | NIKON CORPORATION and METRIS | 20/8 | Today, 20 August, NIKON CORPORATION announced that the voluntary reopening of the takeover bid on Metris has resulted in ownership of 92.17% of the Metris shares
Leuven, August 20th - As a result of the initial acceptance period of the Takeover Bid and the subsequent voluntary reopening, NIMD holds 92.17% of the Metris shares. NIMD will now proceed from August 31, 2009 to September 18, 2009 to a mandatory reopening of the Takeover Bid, in accordance with Article 35, 1° of the Belgian Royal | | |
| | | CMOSIS Raises 3 Million Euros in Additional Capital for Corporate Expansion | 10/8 | | Antwerp, Belgium, 10 August 2009 -- CMOS image sensor start-up CMOSIS NV has successfully concluded a round of private equity financing totalling 3 million euros from several well-known and highly regarded Belgian high-tech investment firms. Lead investor for this round is ING Corporate Investments of Brussels, Belgium, acting as strategic financial partner. The new round of capitalization for CMOSIS is geared towards the ongoing development of innovative CMOS image sensor technologies and | | |
| | | Deloitte Technology Fast50 and Rising Star competition | 30/7 | Election of the 50 fastest growing technology companies
Deadline for registration: 31 August 2009
For the tenth year Deloitte and its co-sponsors (e.g GIMV) organise the Deloitte Technology Fast50. In this anniversary year the Fast50 election is expanded from the Netherlands to the Benelux.
Participants can be public or private, and encompass all technology industry segments including software, internet, biotech/pharmaceutical/medical equipment, computers/peripherals, | | |
| | | Israel Cleantech Ventures and Capricorn Venture Partners Co-lead a $6 million Series | 29/7 | | Tel Aviv, Israel / Leuven, Belgium - 29 July 2009: Israel Cleantech Ventures (ICV) and Capricorn Venture Partners (CVP) announced today that they have invested $6 million in FRX Polymers, Inc, (FRX) the manufacturer of a new, environmentally friendly family of inherently flame retardant plastics. FRX's products are finding markets as polymeric flame retardant additives and as 'standalone' inherently flame retardant engineering plastics. FRX Polymers is currently in the commercialization stage | | |
| | | Capricorn Cleantech Fund Doubles its Investment in Metallkraft AS | 29/7 | Leuven, Belgium - 29 July 2009: Capricorn Venture Partners announced today that it has doubled
its investment in Norway based Metallkraft AS, Kristiansand.
The Capricorn Cleantech Fund, domiciled in Leuven, Belgium, has acquired an additional 500,000 newly issued shares in Metallkraft under the company's on-going share expansion program. This transaction increased Capricorn Cleantech Fund's ownership in Metallkraft to 7%, doubling its initial
investment from December last year.
The wafer | | |
| | | Nikon Corporation and Metris | 27/7 | Today, 25 July 2009, Nikon Corporation announced that its cash tender offer to acquire all outstanding Shares and Warrants of Metris becomes unconditional as the 85% threshold has been reached
Leuven, July 25th - Nikon Corporation, a pioneer in optical technology, has announced today that its wholly-owned Belgian subsidiary NIMD SPRL ('NIMD') has acquired, during the Initial Acceptance Period which ran from June 24, 2009 until July 22, 2009 (inclusive), 85.25% of the outstanding shares of | | |
| | | NIKON CORPORATION AND METRIS | 3/6 | NIKON CORPORATION files its intention to launch a cash tender offer to acquire all outstanding shares and warrants of Metris
Leuven, June 3rd - Metris N.V., a metrology solutions company, today announces that NIKON CORPORATION, a pioneer in optical technology, has filed with the CBFA (the Belgian supervisory authority) its intention to launch a conditional cash tender offer to acquire all outstanding shares and warrants of Metris N.V. at an offer price of Euro 5.50 per Metris share.
| | |
| | | Business and Financial Update for the First Quarter of 2009 | 20/5 | Leuven (BELGIUM) - May 19, 2009 - TiGenix (NYSE EURONEXT: TIG) gives a business update and reports cash position as of March 31, 2009.
ChondroCelect registration procedure
During the first quarter of this year, the company's activities were primarily focused on resolving the outstanding questions on the ChondroCelect product and process validation
processes that were raised by the regulatory authorities in the 4th quarter of 2008. We have now completed all required validation assays and | | |
| | | Metris 09Q1 trading update: Progressing as planned, confirming 2009 outlook | 15/5 | Leuven, May 13th 2009 - Metris, leading innovator in the metrology industry, today issues its Q1 2009 qualitative trading update. The group will announce its H1 2009 results on August 27th, 2009.
During Q1 09, sales came in on plan realizing double digit sales growth compared to Q1 08, despite the continuing recession. Investments in optical metrology systems serving productivity and process optimization proved more recession resilient than the investments in classical mechanical measuring | | |
| | | Second Round of Financing For Image Sensor Startup CMOSIS | 11/5 | Antwerp, Belgium, 08 May 2009 -- CMOSIS NV has successfully concluded its second round of financing by raising ? 1.11 m from present shareholders, new personnel and management. The new investment is earmarked for the ongoing development of new CMOS image sensor technologies and further business expansion. The second round of financing coincides with the appointment of Luc De Mey as CMOSIS CEO and President. Guy Meynants will become VP R&D.
'CMOSIS's first 18 months of operation have confirmed | | |
| | | CMOSIS Second Financing Round - Luc De Mey Joins as CEO | 8/5 | | CMOSIS NV has successfully concluded its second round of financing by raising EURO 1.11M from present shareholders, new personnel and management. The new investment is earmarked for the ongoing development of new CMOS image sensor technologies and further business expansion. The second round of financing coincides with the appointment of Luc De Mey as CMOSIS CEO and President. Guy Meynants will become VP R&D. | | |
| | | Option reports First Quarter 2009 results | 30/4 | | Leuven, Belgium - April 30, 2009 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results for the first quarter ended March 31, 2009. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union (IFRS). The accounting policies and methods of computation followed in the attached financial statements are the | | |
| | | IMEC launches new start-up PEPRIC | 3/4 | Leuven, Belgium - April 3, 2009 - IMEC announces the start of PEPRIC NV, a new company that will develop and commercialize molecular and functional imaging technology based on magnetic nanoparticles. Pepric's technology addresses pharmaceutical applications for drug development and preclinical studies.
The demand for targeted healthcare, specifically targeted to the problem zone in the body, increases as this can reduce the side effects to a minimum. With its Human++ program, IMEC aims to | | |
| | | METRIS: 2008 SALES GROWTH HALTS AND EBIT TURNS NEGATIVE | 18/3 | SWIFT ACTIONS TAKEN DURING 2008 ENABLE ADEQUATE POSITIVE FREE CASH FLOW FOR 2009
HIGHLIGHTS
- Sales growth in 2008 halts with sales declining 4% over 2007 to ?89 million
- 50% gross profit margin in 2008 versus 51% in 2007, the decline due to higher amortizations
- 2008 EBITDA came in just above break-even at ?3.7 million
- 2008 EBIT turned negative to -?9.7 million
- 2008 showed a net loss of ?14 million or ?1.1 net loss per weighted average undiluted share
- Net debt has increased | | |
| | | TiGenix gives business update and announces the full year 2008 financial results | 17/3 | Leuven (BELGIUM) - March 16, 2009 - TiGenix (NYSE EURONEXT: TIG) gives an update of business activities and announces its financial results for the full year ending December 31, 2008.
Business Highlights
Preparing for European launch of ChondroCelect
- ChondroCelect three-year clinical data analysis confirms clinical superiority
- EMEA registration procedure progressing
- CHMP opinion anticipated by end of H1 2009
- More than 500 patients treated with ChondroCelect to-date
| | |
| | | Option reports Fourth Quarter and Full Year 2008 results | 5/3 | | LEUVEN, Belgium - March 5, 2009 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results (regulated information) for the full fiscal year and fourth quarter ended December 31, 2008. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union. The accounting policies and methods of computation followed in | | |
| | | XYLOPHANE AB | 28/1 | CAPRICORN CLEANTECH FUND AND SEB VENTURE CAPITAL
INVEST EUR 3.3 MILLION IN XYLOPHANE AB
Leuven - 27 January 2009, Capricorn Venture Partners announced today its investment in Sweden based Xylophane AB, Gothenburg.
Xylophane AB, developer of a unique renewable packing material that extends the shelf life of sensitive food products, has raised ? 3.3 million (34 MSEK) in an issue of new shares. SEB Venture Capital and Capricorn Cleantech Fund joined as new investors. The capital ensures the | | |
| | | CAPRICORN CLEANTECH FUND INVESTS ? 3.5 MILLION IN METALLKRAFT AS | 22/12 | Leuven - 18 December 2008, Capricorn Venture Partners announced today its investment in Norway based Metallkraft AS, Kristiansand.
The wafer cutting process, a crucial step in the production of silicon solar modules, requires large amounts of cutting slurry. The slurry consists of abrasive silicon carbide particles and glycol, and is quickly polluted during the cutting process by silicon dust, metal particles from the saw wire and
water.
Metallkraft has introduced a patented technology that | | |
| | | GIMV: Successful first closing XL fund at EUR 500 million | 19/12 | 18-12-2008 10:00
Gimv announces today the successful first closing of the XL fund at EUR 500 million. The XL fund, which has been initiated by Gimv, focuses on growth companies with an enterprise value between EUR 75 and EUR 750 million. These companies typically show healthy activity and have the potential to expand their business from the Flemish to the international market. Because of its high importance to the Flemish economy, the fund is also backed by the Flemish Government.
XL gets | | |
| | | Deloitte Fiduciaire maakt resultaten bekend van haar 'KMO Kompas 2008 - 10 financiële sleutels om uw onderneming te sturen' | 8/12 | - Een KMO financiert zich per 5,8 keer meer met eigen middelen dan met bancair vermogen
- 75% van KMO allicht voldoende gewapend tegen financieel-economische crisis, maar.
- Energiekosten 2,5 maal sneller gestegen dan index consumptieprijzen
- Budget reclameuitgaven laatste 4 jaar gedaald
- Totale belastingdruk op KMO sterk onderschat
Brussel, 26 november 2008 - Deloitte Fiduciaire, marktleider inzake accountancy, fiscaal-juridisch en financieel advies aan familiale ondernemers en KMO's, | | |
| | | Aristo Music receives capital injection of 2.6 million euros | 26/11 | Financing must enable international growth
Aristo Music, specialist in new selection and distribution techniques for digital music, has today announced a capital increase for an amount of 2.6 million euros. The new resources
will be used first and foremost for the international expansion of its activities. The parties involved in this round are LRM, KBC Arkiv and the Baekeland Fonds II and the Gemma Frisius
Fonds II that was already a shareholder.
Aristo Music is a Limburg-based company | | |
| | | Metris 08Q3 trading update | 21/11 | EBITDA on track,cCoping with recession through new revenue and cost initiatives to reach 08 plan.
Leuven, November 18th 2008 - Metris, leading innovator in the metrology industry, today issues its 08Q3 qualitative trading update, in line with article 14 of the Royal Decree of November 14th, 2007. The group will announce its H2 and full year 2008 results on March 18th, 2009.
After publishing 08H1 figures on track, 08Q3 gross profit and EBITDA have come in on track as well. Sales did grow | | |
| | | Business and Financial Update for the Third Quarter of 2008 | 5/11 | Leuven (BELGIUM) - November 5, 2008 - TiGenix (NYSE EURONEXT: TIG) gives a business update and reports cash position as of September 30, 2008.
Highlights
- Further data analysis confirms clinical superiority of ChondroCelect
- ChondroCelect registration procedure progressing
- European cell expansion facility obtained GMP status
- TiGenix' core patent granted in US
- Cash position of EUR 29 million on September 30, 2008
Further data analysis confirms clinical superiority of | | |
| | | Openbaarmaking van belangrijke deelnemingen. | 3/11 | Leuven (België) - 3 november 2008 - TiGenix (NYSE Euronext Brussel: TIG) kondigt aan dat het transparantieverklaringen heeft ontvangen van verschillende belangrijke
aandeelhouders overeenkomstig Artikels 14 en 29 van de nieuwe Belgische transparantiewetgeving (Belgische wet van 2 mei 2007 - Koninklijk Besluit van 14 februari 2008) betreffende belangrijke deelnemingen in emittenten waarvan de aandelen zijn toegelaten tot verhandeling op een gereglementeerde Belgische markt.
TiGenix heeft | | |
| | | Option reports Third Quarter 2008 results | 30/10 |
LEUVEN, Belgium - October 30, 2008 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results for the third quarter ended September 30, 2008. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union. The accounting policies and methods of computation followed in the attached financial statements are the | | |
| | | AVANTIUM COMPLETES EUR18 MILLION FINANCING ROUND | 29/10 | Amsterdam, October 29, 2008 -
Avantium announced today the successful completion of a EUR 18 million private financing round. Avantium is active in
the development and commercialization of Furanics, Avantium's next generation biofuel and bioplastic, and the improvement of pharmaceutical products. The financing will be used to accelerate its two proprietary development programs. The focus of the next-generation biofuel and bioplastic
program is on large scale production of Furanics and | | |
| | | Capital-E investeert in Movidia Ltd (Ierland) | 20/10 | Movidia secures funding to enable budding 'Spielbergs on the move'
On-device video production for social networking will be a key differentiator for mobile phones.
Dublin, Ireland & Hong Kong - 20th October 2008 - Movidia, the mobile video processor company, announced today that it had secured over US$14 million in Series A funding. Investments from an international syndicate led by Celtic House Venture
Partners and Capital-E and including Emertec Gestion, AIB Seed Capital Fund and | | |
| | | TRINEAN announces closing of a 3,5 million Euro funding round. | 20/10 | Belgium, Gentbrugge, October 20, 2008
Trinean NV, an innovative player in the sector of molecular instrumentation, today announced the closure of a 3,5 million EURO round of financing. The round was co-lead by new investor Vesalius Biocapital and existing investor Capital-E.
Trinean (www.trinean.com) is a spin-off of the University of Ghent (Intec) and the Belgium nanoelectronics research center IMEC. The company develops and markets the first nanoliter spectrophotometer with | | |
| | | IPCOS acquires Aptitude Ltd | 16/10 | Today, IPCOS announced it has acquired a majority stake in Aptitude Ltd, a UK-based company focusing on delivery of high-performance Advanced Process Control (APC) solutions to the refining and petrochemical markets and the development of high-end APC software tools. Aptitude has offices in Cambridge, UK, and Chandigarh, India. Aptitude will change its name to IPCOSAptitude and become a member of the IPCOS group.
'We're extremely pleased that the Aptitude team is joining our ranks', said | | |
| | | PNO neemt de Belgische en Nederlandse Deloitte Grants & Incentives-afdelingen over | 2/10 | Arnhem/Brussel, 2 oktober 2008
PNO Consultants heeft vandaag de overname bekend gemaakt van de Grants & Incentives afdeling van Deloitte in Nederland en België. De 25 Deloitte medewerkers worden opgenomen in de Nederlandse en Belgische vestigingen van PNO. Deloitte trekt zich terug uit deze markt om haar onafhankelijkheid als audit organisatie te onderstrepen. Voor PNO betekent de overname een versterking van de marktpositie in Nederland en België. Er zijn geen financiële details bekend | | |
| | | Capricorn Venture Partners continues its expansion into cleantech | 19/9 |
Sitra joins as a strategic partner
Over the summer the Belgium based venture capital firm Capricorn Venture Partners has been busy expanding its cleantech franchise. With investments in Ensartech bv, Fluxome Sciences A/S, Alaska Food Diagnostics Ltd and Concentrator Optics GmbH, Capricorn has been expanding its cleantech portfolio to a total of 7 investments. In line with Capricorn's approach to the clean technology sector these investments cover a broad range of different subsectors, | | |
| | | Tigenix: GEREGLEMENTEERDE INFORMATIE - 15 SEPTEMBER 2008 | 16/9 | Openbaarmaking krachtens de Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in emittenten.
Leuven (België) - 15 september 2008 - TiGenix (Euronext Brussel: TIG) publiceert vandaag de informatie in overeenstemming met artikels 15, 18 en 29 van de Wet van 2 mei en het Koninklijk Besluit van 14 februari 2007 betreffende de openbaarmaking
van belangrijke deelnemingen in emittenten waarvan de aandelen zijn toegelaten tot de verhandeling op de Belgische gereglementeerde markt. | | |
| | | CAPRICORN CLEANTECH FUND MAKES INVESTMENT IN CONCENTRATOR OPTICS GmbH | 11/9 | Leuven - 11 September 2008, Capricorn Venture Partners announced today its investment in Germany based Concentrator Optics GmbH, Marburg.
Concentrator Optics engages in the design and production of Fresnel lenses for concentrating photovoltaics (CPV). Manufacturers of CPV modules need Fresnel lenses in order to concentrate incident light onto modern multi-junction devices with high power conversion efficiency.
The market for solar Fresnel lenses is estimated to reach ? 200 million in 2011. | | |
| | | Tigenix: Business Update and Financial Results for First Half of 2008. | 28/8 |
Leuven (BELGIUM) - August 28, 2008 - TiGenix (NYSE EURONEXT: TIG) gives an update of the business activities and announces the financial results for the half year ending June 30, 2008.
Business Highlights
- ChondroCelect (TGX001) three-year clinical data confirm clinical benefit
- EMEA registration procedure ongoing, CHMP opinion anticipated by end of 4th quarter 2008
- Commercial team strengthened in anticipation of the ChondroCelect launch
- Pipeline development progressing
| | |
| | | Metris H1 2008 on track, Full year outlook reconfirmed | 28/8 |
* Sales increased 33.7% compared to H1 2007 and came in at ?48.4 million, sales in local currencies increased with 46.3%, organic sales growth in local currencies came in at 18.7%
* Very strong growth of optical sales (+ 74.7%)
* Results came in as expected given sales seasonality and acquisitions:
- Gross profit margin came in at 47.4%
- EBITDA came in at ?3.5 million
- Net result came in at -?0.9 million
- Earnings per share came in at -?0.07
More information on | | |
| | | Option unveils Compal as first MID customer | 20/8 | | IDF, San Francisco, USA - August 19, 2008 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced that its embedded wireless modules and Linux-based connection management software have been selected by Compal Electronics (Taiwan: 2324.tw) to provide HSPA 3G connectivity to a new range of Mobile Internet Devices (MIDs). The Compal Group is the world's second largest original device manufacturer (ODM) - a specialist manufacturer of products on behalf | | |
| | | Capricorn leads £ 4.5 million investment in Alaska Food Diagnostics Ltd. | 11/8 | Funding to accelerate commercial roll-out of revolutionary fastrAKT pathogen detection technology
Porton Down, UK fastrAKT, the revolutionary pathogen detection technology from Alaska Food Diagnostics Ltd (AFDL), has attracted over £ 4.5 million investment from a European and London based syndicate comprising Capricorn Venture Partners, ICOS Capital, Quest for Growth and Richmond Park
Capital, and advised by Andeman Plc.
The additional funding will allow AFDL to accelerate the | | |
| | | HANSJORG SAGE TO BECOME RESPONSIBLE FOR Gimv's ICT | 28/7 | GIMV, one of Europe's most important private equity and venture capital providers, is pleased to announce today that Hansjörg Sage joined as a Partner. Simultaneously, two
other Investment Managers have joined the company. Hansjörg will head GIMV's ICT (Information & Communication Technology) investment activities in the German speaking countries. The two Investment Managers will reinforce GIMV's vertical sector knowledge in electronics and telecommunication.
Hansjörg said 'I was attracted | | |
| | | Capricorn Venture Partners leads EUR 13.4 million funding for Fluxome Sciences | 24/7 | Capricorn Venture Partners announced today that it led a ? 13.4 million capital increase for Fluxome Sciences in Copenhagen, Denmark. Its Capricorn Cleantech Fund will contribute ? 5 million to this round of financing.
The DKK 100 million / ? 13.4 million capital increase has been secured through a continued strong commitment from current investors SEVENTURE Partners (France), INCUBA Venture (Denmark),
VECATA Venture (Denmark) and the addition of one of Europe's leading cleantech funds, | | |
| | | Option reports Second Quarter and First Half Year 2008 results | 24/7 | | Leuven, Belgium - July 24, 2008 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results for the second quarter and the half fiscal year ended June 30, 2008. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union. The accounting policies and methods of computation followed in the attached financial | | |
| | | Gimv appoints Koen Dejonckheere as CEO | 15/7 | the Board of Directors of GIMV appointed Koen Dejonckheere as the new CEO of GIMV, replacing Dirk Boogmans. It is expected that Koen Dejonckheere will start in his new function on 1 October 2008. Until that time President Herman Daems, as announced previously, will continue to take on the responsibilities of the President-CEO.
Koen Dejonckheere is Managing Director and head of Corporate Finance at KBC Securities until now. Before that he worked for Nesbic, Halder, Price Waterhouse Corporate | | |
| | | TiGenix awarded European Union grant | 11/6 |
Leuven (BELGIUM) - June 10, 2008 - TiGenix (EURONEXT: TIG) announced today that it has been awarded a EUR 1.2 million grant from the European Union for its participation in TREAT-OA, a research consortium focused on the development of novel diagnostics and treatments for osteoarthritis.
The TREAT-OA consortium brings together a selected team of academics, clinicians and industry experts. This five-year research program represents a large-scale, integrated and trans-disciplinary project that | | |
| | | Growth finance Bafa | 6/6 | Fin.Co invests in BAFA (Ben-Air Flight Academy)
Antwerp/Brussels - 5 May 2008
Fin.Co has acquired a significant minority stake in BAFA, a leading Belgian Flight Training Organisation based at the International Airport of Antwerp.
Founded in 1980, BAFA (www.bafa.be) offers a broad range of training programs for professional and private pilots, based on the most recent European licensing requirements. The company envisages the highest quality standards for its training courses and works | | |
| | | Amplexor kent aanhoudende groei in 2007 | 6/6 | Leuvense ECM-specialist ziet omzet stijgen en breidt verder uit
Leuven, 5 juni 2008 - Amplexor, specialist in enterprise content management (ECM), heeft alweer een uitstekend jaar achter de rug. Niet alleen kende het Belgische IT-bedrijf een significante winststijging, maar het genereerde in 2007 ook een omzet van meer dan 4 miljoen euro, een stijging met meer dan 35% ten opzichte van 2006.
Sterke omzetstijging en uitbreiding
'We hebben een mooi jaar achter de rug', aldus Eric Pieters, | | |
| | | Tate & Lyle Ventures and Agri Investment Fund invest in gut-health technology company | 4/6 | Tate & Lyle Ventures and Agri Investment Fund have co-led a EURO 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health.
Fugeia is a spin-out company from the Katholieke Universiteit Leuven (K.U. Leuven), whose own Gemma Frisius Fund has co-invested, and the University College Sint-Lieven (KaHo Sint-Lieven).
The founders Professor Jan Delcour (Head of the Laboratory of Food Chemistry and Biochemistry of K.U.Leuven) and Professor Willem | | |
| | | Capricorn Venture Partners closes its Cleantech Fund at Euro 100 million | 21/5 | Last week Capricorn Venture Partners held the final closing of its Capricorn Cleantech Fund well above its original fundraising target, at over Euro 100 million. Three existing investors, PMV
(ParticipatieMaatschappij Vlaanderen), Ethias and a Dutch pension fund, increased their participation in the fund. In addition Capricorn welcomed the Solvay Group as a strategic partner and over 15 private investors as new shareholders to the fund.
'These are exciting times,' says Dr Jos B. Peeters, | | |
| | | Option reports first quarter 2008 results | 24/4 | | Leuven, Belgium - April 24, 2008 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results for the first quarter ended March 31, 2008. The financial information reported in this release is presented in Euros and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union (IFRS). The accounting policies and methods of computation followed in the attached financial statements are the | | |
| | | Annual report 2007 of FMTC is available | 21/3 |
Flanders' MECHATRONICS Technology Centre vzw (FMTC) 2007 annual report can been downloaded from the organisation's web site (www.fmtc.be). The annual report includes an overview of FMTC's evolution and research activities in 2007. Also a short description of the research projects to be started up in 2008 is provided.
In 2007, FMTC successfully passed a mid-term evaluation by IWT and the Flemish government. FMTC has realised all of its technological targets. The member companies' | | |
| | | METRIS REALIZES 50% SALES GROWTH AND NEARLY DOUBLES NET PROFIT IN 2007 | 19/3 | HIGHLIGHTS
- Sales in 2007 increased 50% over 2006 to ?93 million
- 30% organic sales growth, 20% through acquisitions
- 51% gross profit margin in 2007 versus 54% in 2006
- 2007 EBITDA increased 30% over 2006 and came in at ?16 million
- 2007 EBIT increased 33% over 2006 to ?7,5 million
- 2007 net profit increased 93% to ?7,0 million from ?3,6 million in 2006
- 2007 earnings per weighted average undiluted share was ?0,57
Sales increased 50% from Eur 62 million in 2006 to Eur 93 | | |
| | | Four Institutional Investors join the Capricorn Cleantech Fund | 5/3 | Early February, Capricorn Venture Partners welcomed four additional investors to its latest Capricorn Cleantech Fund, increasing the fund's capital with over EUR 30 million. In addition to the European Investment Fund, the fund's investor base was also strengthened by institutional investors Dexia
Bank, Ethias and Quest for Growth. Capricorn aims to close fundraising for its Cleantech Fund by the end of the first quarter of 2008 with a target fund size between EUR 80 and 100 million.
In | | |
| | | NEOSENS CLOSES FUNDING ROUND OF 2.5M euro | 3/3 | TOULOUSE, France I February 25th , 2008 - Neosens, a company specialized in microelectronics based sensor technology used to monitor fouling and dissolved oxygen in industrial processes, announces the closing of 2.5M euro in capital funding. The group of investors, led by SOFINNOVA Partners, includes the Belgian fund, Capricorn Cleantech Fund and GALIA Gestion, and the original investors, ICSO Private Equity and IRDI.
Neosens was founded in 2001 in Toulouse, France by Laurent Auret after | | |
| | | Amplexor door Alfresco uitgeroepen tot Europese Partner van het Jaar | 3/3 | Leuvense specialist gelauwerd voor uitgebreide expertise
Leuven, 29 februari 2008 - Amplexor, specialist in enterprise content management (ECM), krijgt van Alfresco, wereldleider op het vlak van open source ECM-oplossingen de award 'European Partner of the Year'. Deze award is een erkenning voor de inspanningen die Amplexor leverde, zowel in het uitbouwen van haar expertise rond deze open source ECM-oplossing, als in de promotie en verkoop naar de publieke en private sector.
Eén van de | | |
| | | KLA-Tencor Announces Intent to Acquire Belgium's ICOS Vision Systems | 22/2 | (Announcement made in accordance with article 8 of the Belgian royal decree of April 27, 2007 on takeover bids)
KLA-Tencor's Global Market Presence to Help Accelerate
ICOS's Growth and Expand KLA-Tencor in Solar and Other Emerging Markets
SAN JOSE, California, and LEUVEN, Belgium - February 21, 2008 - KLA-Tencor Corporation (NASDAQ: KLAC)and ICOS Vision Systems Corporation NV (Euronext: IVIS) today jointly announced an agreement under which KLA-Tencor will make a | | |
| | | TiGenix announces changes to Board of Directors | 21/2 | Leuven (BELGIUM) - February 20, 2008 - TiGenix (EURONEXT: TIG), the biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints announces the resignation of Capricorn Venture Partners, represented by Mr. Claude Stoufs as Director.
Mr. Claude Stoufs served as a dependent Non-Executive Director representing Capricorn Venture Partners since 15 September 2003 when Capricorn Venture Fund II became shareholder of the Company. The resignation of Capricorn | | |
| | | OPTION INDICATES PRELIMINARY Q4 AND FULL YEAR 2007 RESULTS | 25/1 | Leuven, Belgium - January 25, 2008 - Option N.V. (Euronext: OPTI; OTC: OPNVY), the wireless technology company, today announced that pre-audited preliminary revenues for the fourth quarter of fiscal year 2007 will be in the range EUR 67-70 million, which includes certain extraordinary adjustments, representing a minimum growth of 6% over Q4 2006. Full year revenue will be in the range of EUR 298-301 million
representing a minimum growth of 7% versus full year 2006. EBIT for the quarter will be | | |
| | | Gemma Frisius Fonds: 10 jaar zaaikapitaal voor onderzoek | 26/11 | | Het Gemma Frisius Fonds (GFF) bestaat 10 jaar. Het fonds werd opgericht in 1997 door K.U.Leuven Research & Development, KBC Private Equity en Fortis Private Equity, met als doel wetenschappelijk onderzoek te helpen vertalen naar innovatieve, commercieel beschikbare producten en diensten. De visie van het GFF bestaat erin om kansen te geven aan beloftevolle initiatieven en niet onmiddellijk terug te deinzen voor berekende risico's. Het GFF staat open voor elk type technologie ontwikkeld binnen de | | |
| | | Light Blue Optics raises US$26 million to accelerate development of laser-based miniature projection systems | 2/10 |
**Largest Series 'A' funding round in European electronics sector for past 5 years**
**Funding round to accelerate product development programme**
Cambridge, UK, October 1, 2007-- Light Blue Optics (LBO), the industry-leading developer of holographic laser projection technology, today announced closing a US$26 million Series 'A' funding round, led by Earlybird Venture Capital and Capital-E. Existing investors 3i plc, who led LBO's US$3.5 million seed-funding round, and NESTA also | | |
| | | Capricorn Venture Partners hits half-way milestone with EUR 50 million for its latest Capricorn Cleantech Fund | 2/10 | | Leuven, Belgium, 28 September 2007 - Today the Belgian based venture capital firm Capricorn Venture Partners announced that it signed up LRM, the regional investment company for Limburg (Belgium) as investor to its Capricorn Cleantech Fund. The Capricorn Cleantech Fund held its first closing in November 2006. Including LRM's investment of EUR 10 million, the Fund reached its half-way milestone of EUR 50 million. Other investors in the Fund include Electrabel (a member of the Suez Group), | | |
| | | TiGenix - Business Update and Financial Results for First Half of 2007 | 3/9 | Leuven (BELGIUM) - August 30, 2007 - TiGenix (EURONEXT: TIG) gives an update of its business activities and announces its financial results for the half year ending June 30, 2007.
Business Highlights
- Successful completion of ChondroCelect pivotal phase III trial
- ChondroCelect enters registration phase
- Strategic alliance with Fidia Advanced Biopolymers
- Next generation ChondroCelect 3D (TGX002) development on track
- US manufacturing facility acquired and team in place
| | |
| | | OPTION ANNOUNCES FIRST HALF AND SECOND QUARTER RESULTS FOR 2007 | 26/7 | Leuven, Belgium - July 26, 2007 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company,
today announced its results for the first half year and the second quarter ended June 30, 2007. The financial information
reported in this release is presented in Euro and has been prepared in accordance with the recognition and measurement
criteria of IFRS as adopted by the European Union (IFRSs). The accounting policies and methods of computation followed in the
attached | | |
| | | Metris expands shareholder base | 19/7 |
Leuven, July 19th 2007 - Metris (MTRS, Euronext Brussels) has been informed today that 811,608 existing shares have been successfully placed outside the order book with existing and new institutional European investors through KBC Securities.
Given the broad appetite for Metris' shares amongst renowned institutional investors, 811,608 shares from various NIF funds have been successfully placed on July 18th 2007. The shares from the selling shareholders could only be traded in consultation | | |
| | | Carbonics | 20/6 | Met Carbonics mikt Capital-E op een doorbraak in vermogenselektronica.
ZAAIGELD
Deze investering is een zogenaamd 'zaaigeld-project' wat betekent dat het om risicovolle, nog niet bewezen projecten gaat. Carbonics, is de meest risicovolle zet van Capital-E - een durfkapitaalfonds verbonden met het Leuvens onderzoekslabo Imec uit het Arkimedes-programma maar de omvang van de investering is beperkt (150.000 euro) en het potentieel hoog.
'De idee is om schakelaars te maken in kunstdiamant wat | | |
| | | Metris acquires Italian metrology company Garda | 15/6 | Leuven, June 15th 2007 - Metris (MTRS, Euronext Brussels) announces that it has signed a share purchase agreement with the shareholders of Garda S.r.l. for the purchase of 100% of the Garda stock. Metris has also signed asset purchase agreements with Tomelleri S.r.l. and Mr. Tomelleri for the acquisition of the underlying IPR. These purchases are considered as technology acquisitions to further complete the Metris product portfolio.
Garda S.r.l. is an Italian manufacturer of portable | | |
| | | Capital-E announces that Rudi Severijns has joined the team as fourth partner. | 9/5 | 9 May 2006
Capital-E, an early stage venture fund focusing exclusively on 'enabling micro-electronics', announces that Rudi Severijns has joined the team as fourth partner. Rudi comes from GIMV, where he was an executive investment manager in the ICT group since 2000. Recent investments include CoreOptics (Germany/US) and Virtensys (UK).
Beside the international VC experience, Rudi brings a wealth of industry and technology expertise as well as business development skills to Capital-E. | | |
| | | OPTION REPORTS FIRST QUARTER 2007 RESULTS | 26/4 | Leuven, Belgium - April 26th, 2007 - Option N.V. (EURONEXT Brussels: OPTI; OTC: OPNVY), the wireless technology company, today announced its results for the first quarter ended March 31, 2007.
The financial information reported in this release is presented in Euro and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union (IFRSs). The accounting policies and methods of computation followed in the attached financial statements are | | |
| | | Quest for Growth: Net Asset Value per share on 21 March 2007 | 23/3 | As from 22 March 2007, Quest for Growth shares will be quoted ex-coupon.
Based on the European closing prices of Wednesday, March 21st and the dividend payment of the following day, the NAV at the market opening on Thursday, March 22nd is estimated at 10.47 euro.
The Extraordinary General Meeting of Quest for Growth last week approved a proposal to increase the company's share capital. Quest for Growth will issue a maximum of 2,333,715 new ordinary shares at a price
range between 7.50 euro | | |
| | | Quest for Growth, best communicator to the broad market. | 23/3 | The weekly magazine Cash today announced the winners of its Cash Investor Relations Award. The prize acknowledges the company listed on the Brussels Euronext stock exchange which best communicates with its shareholders. For companies outside of the Bel-20, the award goes to Quest for Growth and Cumerio.
In order to qualify for this prize, companies must pass through a two-part selection process. To begin with, the websites of various companies are reviewed. Things they look for include the | | |
| | | Punch Telematix exceeds own expectations | 28/2 | Wervik, Belgium - 28 February 2007
Punch Telematix, a growing and innovative telematics company whose stock is listed and which is active in Belgium, the Netherlands and France, achieved a turnover of 18.8 million euro in financial year 2006, an increase of 162% over 2005. Thanks to the increase in scale as a result of various acquisitions, the group is profitable for the first time, with positive results of operating activities of 0.7 million euro and a net profit of 0.3 million euro. With | | |
| | | | | TiGenix announces positive phase III results and plans listing on Euronext Brussels | 19/2 | Leuven (Belgium), February 19, 2007 - TiGenix, the late-stage biomedical company focused on innovative local treatments for damaged and osteoarthritic joints, announced today that:
- The results of a phase III landmark trial comparing its lead product ChondroCelect to current standard of care for cartilage defects in the knee were presented by Dr. Daniël Saris (University Medical Centre Utrecht) at the annual meeting of the American Academy of Orthopaedic Surgeons in San Diego, United States. | | |
| | | Quest for Growth intends to boost its capital | 1/2 | This capital increase has to offer shareholders the opportunity to reinvest their dividends from the financial year 2006.
On 18 January Quest for Growth already announced a net profit of EUR 21.5 million for the fiscal year ending on 31 December 2006. The Board of Directors will propose the distribution of a gross dividend at EUR 1.94 (net EUR 1.93) during the General Assembly of 15 March 2007. This means a distribution of 100% of the financial year's profit.
However, because the company | | |
| | | Leeport Group form Partnership with Metris | 19/1 | Initial order for Metris equipment worth more than 4 million euro
Leuven, 18 January 2007 -Metris, the total metrology solution provider, and Leeport Group, the foremost metrology distribution company in Greater China have agreed a sales, service and marketing partnership that will dramatically raise the Metris profile in this rapidly expanding region. Metris has taken an initial order worth more than 4 million euro and will be equipping the Leeport demonstration centers as well as meeting a | | |
| | | Exercise of the Over-Allotment Option of Metris public offer | 16/1 | Leuven, January 15th 2006 - Metris (Euronext Brussels: MTRS), the total metrology solution provider and Belgium's 'Entrepreneur of the Year 2006', today announces that following its successful IPO and listing on Eurolist by Euronext Brussels the Over-allotment Option was exercised by KBC Securities, the Lead Manager, at the offer price, i.e. ?12, in accordance with the terms and conditions described in the prospectus.
Following the exercise of this option with respect to 1,044,790 existing | | |
| | | OPTION indicates preliminary full-year revenues | 5/1 | Leuven, Belgium - January 5, 2007 - Option N.V. (Euronext: OPTI; OTC: OPNVY), the wireless technology company, today announced that its pre-audited preliminary revenue projections for fiscal year 2006 will be 278 million Euro, representing an increase of 40 per cent compared with 198.6 million Euro in fiscal 2005.
Before year end, management secured substantial savings in the cost of goods sold and IPR and royalty payments that resulted in a higher than anticipated full year EBIT margin of | | |
| | | METRIS raises 65 million eur at 12 eur per share in successful IPO - Offering oversubscribed 3.8 times | 13/12 | Leuven, December 11, 2006 - Metris, the total metrology solution provider and Belgium's 'Entrepreneur of the Year 2006', has successfully completed its initial public offering (IPO) and will be listed as of tomorrow on the Eurolist by Euronext Brussels under the symbol MTRS.
Pursuant to the offering, 5,416,666 new shares, equivalent to eur 65 million, were issued by Metris and 1,666,667 existing shares, equivalent to eur 20 million, have been offered by the selling shareholders. As lead | | |
| | | Kapitaal-injectie voor TriPhase | 8/12 | TriPhase nv, een recente spin-off die zich toelegt op snelle prototyping van vermogenelektrische sturingen, verhoogt zijn kapitaal en verwerft intellectueel eigendom van de Katholieke Universiteit Leuven.
Op donderdag 7 december voert TriPhase een kapitaalsverhoging door en treden een aantal privé-investeerders, Allegro Investment Fund, het Gemma-Frisius II fonds en het department Elektrische Energie & Computerarchitecturen van de KULeuven toe tot het maatschappelijk kapitaal. Samen met een | | |
| | | OPTION UNVEILS GLOBETROTTER EXPRESS 7.2 | 5/12 | ExpressCard/ 34 - HSDPA 7.2Mbps - Worldwide use -
Superior Antenna Performance
LEUVEN, Belgium - December 5, 2006 - Option N.V. (Euronext: OPTI; OTC: OPNVY), the wireless technology company, today unveiled its first ExpressCard wireless data card, the GlobeTrotter EXPRESS 7.2. ExpressCard technology is the latest hardware expansion based on the PCI-standard for mobile computers. The new product will satisfy the requirements of the notebooks coming into market with this type of data card | | |
| | | Metris IPO starts Monday November 27, 2006 - Price range set at 10,5 euro to 13,5 euro per share | 24/11 | Leuven, 24 November 2006 - Metris, the total metrology solution provider and Belgium's 'Entrepreneur of the Year 2006', announces its IPO on Eurolist by Euronext Brussels. The offering period starts Monday, 27 November 2006. The total transaction value amounts up to EUR 85 million, of which maximum EUR 65 million of new shares with VVPR strips and maximum EUR 20 million of existing shares are offered, excluding an over-allotment option of 15%. KBC Securities acts as lead manager for the IPO.
| | |
| | | | | Option reports third quarter 2006 results | 26/10 | | Leuven, Belgium - October 26th, 2006 - Option N.V. (EURONEXT Brussels: OPTI; OTC:OPNVY), the wireless technology company, announced today its results for the third quarter and first nine month period ended September 30th, 2006. The financial information reported in this release is presented in Euro and has been prepared in accordance with the recognition and measurement criteria of IFRS as adopted by the European Union (IFRSs). The accounting policies and methods of computation followed in the | | |
| | | Metris verkozen tot 'Onderneming van het jaar' | 25/10 | 
Leuven, 25 november 2006 - Het Leuvense technologiebedrijf Metris International is de laureaat van de twaalfde editie van de verkiezing van de 'Onderneming van het Jaar'. Ernst & Young organiseert deze award in samenwerking met De Tijd, Fortis en Kanaal Z. Het bedrijf wordt geprezen voor zijn dynamisme en zijn kansen uit te groeien tot een wereldspeler.
Metris International werd door de jury gekozen uit een selectie van 6 genomineerde bedrijven: Arinso International, Cegeka Groep, Groep | | |
| | | OPTION indicates preliminary 3Q06 revenues | 6/10 | | Leuven, Belgium - October 5, 2006 - Option N.V. (Euronext: OPTI; OTC: OPNVY), the wireless technology company, today announced that revenues for the three-month period ending September 30, 2006 will be EUR 75+ million with net positive earnings. Although the top line results for the period will be below previous guidance, revenues for the quarter will still represent an increase of 35% compared to the EUR 55.9 million posted in the third quarter of 2005. Full-year revenue growth is now expected | | |
| | | GIMV en KBC investeren in Peakadilly | 23/8 | GIMV, KBC Private Equity, het Nederlandse LSP en andere durfkapitaalgroepen investeren 14,5 miljoen euro in Peakadilly.
Dat Gentse biotechbedrijf specialiseert zich in het opsporen van eiwitten die de aanwezigheid van ziektes kunnen veranderen. Het diagnosticabedrijf richt zich vooral op toepassingen om kanker op te sporen. GIMV investeerde 4,5 miljoen euro in de operatie, die veruit de grootste startkapitaalronde is in de Vlaamse biotechsector. Peakadilly is na Cropdesign, Devgen en Ablynx, | | |
| | | OPTION reports strongest quarter ever as HSDPA launch accelerates | 27/7 | Leuven, Belgium - July 27th, 2006 - Option N.V. (EURONEXT Brussels: OPTI; ADR: OPNVY), the wireless technology company, announced today its results for the second quarter and first half year ended June 30th, 2006.
Highlights of the second quarter and first half year:
· Total revenues for the second quarter of fiscal year 2006 did not only increase by 68.8% to EUR 82.5 million compared with the EUR 48.9 million in the second quarter of 2005 but also exceeded
the total revenues of the first | | |
| | | | | GIMV Invests EUR 4,7 Million in Belgian Clear2Pay | 25/7 | GIMV invests EUR 4,7 million in Belgian softwarecompany Clear2Pay (www.clear2pay.com). This investment is part of a new funding round of Clear2Pay totalling 15,7 million euro.
GIMV invests in Clear2Pay for the first time and acts as co-lead investor together with AGF Private Equity. Other investors in this round are the existing shareholders Intel, Quest for Growth,
Trustcapital Management, Big Bang Ventures and the management of Clear2Pay. No further financial details on this transaction | | |
| | | Alcatel treedt toe tot het Holst Centre via uniek businessmodel | 30/5 | Eindhoven, 30 mei 2006 - Telecommunicatiespecialist Alcatel treedt voor een periode van twee jaar toe tot een van de twee programmalijnen van het Holst Centre, namelijk draadloze autonome sensorsystemen. Door het zogenaamde fellow traveler partnerschap kan Alcatel de marktopportuniteiten voor vaste netwerken en residentiële multimedia-applicaties verkennen en evalueren die uit het onderzoeksprogramma kunnen voortvloeien.
Het concept van het fellow traveler partnerschap is een uniek | | |
| | | Gemma Frisius verhoogt kapitaal. | 24/5 | Persbericht Uitgeversbedrijf Tijd NV- mei 2006
(tijd) - De durkfapitaalfondsen Gemma Frisius van de Katholieke Universiteit Leuven (KULeuven) verhogen hun kapitaal met 6,5 miljoen euro tot 24,9 miljoen euro. De nieuwe middelen komen van de bestaande aandeelhouders (KULeuven, Fortis Private Equity en KBC Private Equity). De Gemma Frisius-fondsen investeren in spin-offs van de Leuvense universiteit.
Het eerste fonds van de KULeuven, Gemma Frisius I, trekt zijn kapitaal op van 12,4 tot 16,4 | | |
| | | Kapitaalsverhoging bij het Belgische ICMS | 4/5 | ICMS, specialist in informatie- en kennisbeheer, investeert in onderzoek en ontwikkeling
Boortmeerbeek, 3 mei 2006 - Het Belgische ICMS, actief op het vlak van informatie- en kennisbeheer, neemt een mooie wissel op de toekomst. Allegro Investment Fund, een vanuit Leuven opererende investeringsgroep die kapitaal verstrekt aan Vlaamse startende hightechbedrijven, investeert in het IT-bedrijf. De kapitaalsinjectie moet de Europese groeiplannen van ICMS helpen waarmaken.
Kapitaal van het | | |
| | | Leuvense Xenics bekroond als Vlaams-Brabantse Young Exporter | 27/4 | Elk jaar wordt door Flanders Investment & Trade (FIT), het Vlaamse Agentschap voor Internationaal Ondernemen, de Leeuw van de Export uitgereikt. Fientje Moerman, viceminister-president van de Vlaamse regering en Vlaams minister van Economie, Ondernemen, Wetenschap, Innovatie en Buitenlandse Handel reikte in het Vlaams parlement in Brussel de trofeeën van 'best Performer' en 'Young Exporter uit'.
De titel van Best Performer wordt toegekend aan een ondernming die reeds over heel wat | | |
| | | | | KBC Private Equity acquires 60% of IPCOS | 31/3 | KBC Private Equity has taken a participating interest of 60% in the Leuven-based technology company IPCOS, active in the development and worldwide sale of automated process control solutions for the chemical, glass and oil industries. The other 40% of the shares remain in the hands of the management and
staff of the company and the K.U.Leuven (Catholic University of Leuven).
The partnership with KBC Private Equity will reinforce both the solid financial position of IPCOS and its current | | |
| | | Central & Eastern Europe - Summary Report on Investment Incentives and Corporate Taxes - 2006 edition | 29/3 | What tax and grants incentive schemes are available in Central and Eastern Europe as of 2006?
The answers can be found in this new report by Business Mobility International. It presents an up-to-date summary on the major tax incentive schemes in 10 Central and Eastern European countries: Bulgaria, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovak Republic and Slovenia. For each available tax incentive scheme a description of the eligibility criteria allows the | | |
| | | Leuvens investeringsfonds Capital-E wil dé referentie worden in Europa | 22/3 | Leuven, 22 maart 2006 -- Het investeringsfonds Capital-E, nauw verbonden aan het Leuvense onderzoekscentrum voor nano-elektronica en nanotechnologie IMEC, kondigt vandaag het succesvol afsluiten van een eerste kapitaalronde aan van 35,5 miljoen euro. Capital-E mikt per jaar op twee tot drie startende micro-elektronica bedrijven in verschillende sectoren. Op termijn wil het fonds de Europese referentie worden in zijn domein.
In april 2005 engageerde het Leuvense onderzoekscentrum IMEC zich om | | |
| | | Maleisische industrieel investeert fors in Leuvense spin-off | 17/2 | Leuven -- 15 februari 2006 --
Essensium NV, aanbieder van oplossingen voor systemen-op-chip (SoC), ondertekent een kapitaalinjectie van de leidinggevende producent van klantspecifieke chips Silterra Malaysia Sdn. Bhd. via het moederbedrijf Khazanah Nasional. De spin-off van het Leuvense onderzoekscentrum IMEC zal het uiteindelijke kapitaal van 6 miljoen euro ontvangen via de investeringsgroep Atlantic Quantum, een zusterbedrijf van Silterra.
Essensium is gevestigd in Leuven en levert | | |
| | | Belgian monitoring software from ServersCheck supplied with Acer EMEA servers | 23/1 | Leuven firm also starts developing a partner network aimed at small to medium-sized organizations
Leuven, 23th January 2006 - ServersCheck, the company from Leuven that supplies monitoring software and hardware for ICT infrastructures, has signed an agreement with the hardware giant Acer. All Acer servers sold in the EMEA region (Europe, Middle-East and Africa) will be now supplied with ServersCheck Monitoring Software. Companies can use this software to monitor the availability and | | |
| | | Introduction of full 1.8 Mbps Wireless Data Card extends Option's leadership in HSDPA | 23/1 | Mobilkom Austria rolls out HSDPA network with Option data cards
Leuven - Belgium, January 23, 2006 - Option N.V. (Euronext: OPTI, OTC: OPNVY), the wireless technology company, continues the successful execution of its HSDPA strategy with the announcement and initial shipment of a new product within its HSDPA portfolio - the GlobeTrotter HSDPA.
The new data card delivers speeds of up to 1.8Mbps over an HSDPA network - 4,5 times faster than maximum data rates available over 3G UMTS. If no | | |
| | | Metris acquires LK, 3D Scanners and Arc Second | 17/1 | 
Three strategic acquisitions position Metris as the Total Solution Provider for Automotive and Aerospace Metrology applications
Leuven, January 17th 2006 - Metris today announces the simultaneous acquisition of LK Ltd. (Derby, UK), 3D Scanners Ltd. (London, UK) and Arc Second Inc. (Virginia, Washington, USA). Total funds in excess of 35 million euro have been raised to finance the acquisition and integration of the three privately held companies.
'Through these acquisitions Metris | | |
| | | BioAlliance Pharma IPO | 15/12 | BioAlliance Pharma SA, a Capricorn Venture Fund portfolio company, has completed a successful admission to Euronext's Eurolist Paris.
30 Million euro Raised at 13.30 euro per share Market Capitalisation of 114 Million euro
9 December 2005 - BioAlliance Pharma SA, a Paris-based biopharmaceutical company focussing on drug resistance through the development and commercialisation of innovative therapeutic products targeting growing markets in cancer, HIV and severe infections, made a stock | | |
| | | Polkomtel launches HSDPA, 3G and Edge Data Cards from Option for the Polish market | 14/12 | | Leuven - Belgium, December 13, 2005 - Option N.V. (Euronext: OPTI, OTC: OPNVY), the wireless technology company, today announced that Polkomtel has selected three wireless data cards from Option's portfolio, the GlobeTrotter 3G/EDGE 'HSDPA-Ready', the GlobeTrotter EDGE and the GlobeTrotter 3G QUAD, to provide data services to its broad base of mobile business users. With over 8 million customers in Poland, Polkomtel markets its services under the 'iPlus' brand. Polkomtel plans to launch HSDPA | | |
| | | Option ships 1 millionth 3G UMTS wireless data card | 10/11 | Leuven - Belgium, November 10, 2005 - Option N.V. (Euronext: OPTI, OTC: OPNVY), the wireless technology company, today announced that it has shipped its 1 millionth 3G UMTS wireless data card. The millionth data card, a customized Vodafone version of the GlobeTrotter 3G QUAD, rolled off of the production lines at Option's logistics facility in Cork (Ireland) this week and was delivered to Vodafone D2 in Germany.
Option announced the development of the first 3G UMTS wireless data card at ITU | | |
| | | | | OPTION POSTS RECORD REVENUES AND NET EARNINGS IN Q3 2005 | 27/10 | Leuven, Belgium - October 27th, 2005 - Option N.V. (EURONEXT Brussels:OPTI;OTC:OPNVY), the wireless technology company, today reported results for the third quarter 2005.
The results are reported in Euro. In line with the regulatory environment the results, as from January 1st 2005, are prepared in accordance with International Financial Reporting Standards (IFRS). 2004 figures, reported under USGAAP rules, have been restated into IFRS and may differ from earnings releases issued in 2004.
| | |
| | | Option data cards at forefront of BT's entry into broadband mobile data solutions | 4/10 | UK operator announces 'BT Datazone' with Globetrotter Fusion Quad and Globetrotter 3G Quad
Leuven - Belgium, October 4, 2005 - Option N.V. (Euronext: OPTI, OTC: OPNVY), the wireless technology company, today announced that BT has selected the GlobeTrotter 3G QUADTM and GlobeTrotter FUSION QUADTM wireless data card devices to launch 'BT Datazone', releasing the full power of mobile broadband data services for its business customers.
BT markets the wireless data cards under Option's own | | |
| | | Lancering van de Ondernemerschapsportefeuille - begin 2006 | 9/9 | Uit een grondige evaluatie van alle bestaande cheque-instrumenten van de Vlaamse regering, is vandaag de ondernemerschapsportefeuille ontstaan. Dit nieuwe systeem moet verhelpen aan de lacunes die de evaluaties bij de huidige instrumenten aan het licht brachten.
De ondernemerschapsportefeuille is een nieuw, geïntegreerd instrument, waarmee kleine en middelgrote ondernemingen via de elektronische weg een aantal diensten kunnen aankopen. Dit eenvoudige, transparante systeem, waarin iedere | | |
| | | TiGenix and ProStrakan enter into OsteoArthritis research collaboration | 15/6 | -- Collaboration focuses on the identification of novel treatments for osteoarthritis by screening ProStrakan's modulator libraries against TiGenix' in-vitro / in-vivo models --
LEUVEN (BELGIUM) - June 15, 2005 - TiGenix NV and ProStrakan Ltd today announced the signing of a collaborative agreement to research and develop novel treatments for osteoarthritis. The companies have initiated a program of collaborative research and development to identify and develop compounds from ProStrakan's | | |
| | | Winnaars Leeuw van de Export 2004 | 19/4 | Leuven, 18 april 2005 - Best en Camco Technologies kregen op 18 april 2005 de Leeuw van de Export 2004 toegekend. Ze werden daarmee bekroond voor hun sterke exportprestaties tijdens het afgelopen jaar. De Leeuw van de Export wordt jaarlijks uitgereikt door Export Vlaanderen, de Vlaamse openbare instelling voor exportpromotie.
De export is voor de Vlaamse economie van levensbelang. Ruim 80% van onze welvaart hebben wij te danken aan wat Vlaanderen verkoopt buiten zijn grenzen.
De eerste | | |
| | | LMS opens representative office in Russia | 13/4 | | Leuven, Belgium - April 5, 2005 - LMS, the engineering innovation company, announces the opening of a representative office in Moscow, Russia. With the opening of the new office, LMS further strengthens its worldwide network of sales offices and establishes a local commercial and support contact for its customers and distributors in Russia, Ukraine and Belarus. Over the past decade, the LMS customer base in the Russian automotive, aerospace and other advanced manufacturing industries has grown | | |
| | | Summary Report on Investment Incentives and Corporate Taxation in Central and Eastern Europe | 12/4 | | What tax and grants incentive schemes are available in Central and Eastern Europe as of 2005? The answers can be found in this new report by Business Mobility International (www.bmintl.com). It provides the reader with an up-to-date summary on the major tax incentive schemes in 10 Central and Eastern European countries: Bulgaria, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovak Republic and Slovenia. For each available tax incentive scheme a description of the | | |
| | | LMS buys out GIMV and welcomes NPM Capital as new minority shareholder | 14/3 | | Leuven, Belgium - March 10, 2005 - LMS, the engineering innovation company, announces today that its principal shareholders have agreed to repurchase the equity participation held in LMS by GIMV, Belgium's leading venture capital provider. GIMV has been a long-standing investor in LMS and has supported the company since 1991 in its successful strategy to become the global leader in physical prototype testing as well as its expansion in the strong growing market of digital prototyping and | | |
| | | | | DIATOS N.V.'s ONCOLOGY RESEARCH BOOSTED BY SIGNIFICANT FUNDING | 16/2 | CONTACTS:
Diatos N.V.
Henk Snyman, MD., Managing Director
+ 32 (0) 478 45 60 77
LEUVEN, BELGIUM- February 16, 2005 - Diatos N.V. announced today that its oncology research programme in Leuven received significant support through a grant from the Flemish Institute for Science and Technology (IWT). Diatos N.V. focuses its research on anti-cancer prodrugs, based on one of Diatos's two core technology platforms, known as Tumor-Selective Prodrug Technology (TSP). The funding of 650,000 | | |
| | | Lustrumviering 'Leuven.Inc - een verhaal van 5 jaar innovatie in netwerking' | 21/12 | Leuven.Inc (Leuven Innovation Networking Circle) ging 5 jaar geleden officieel van start als multidisciplinair ontmoetingsplatform voor technologische groeibedrijven uit de Vlaamse regio en daarbuiten. Wat op 18 november 1999 ontstond onder de bezielende en inspirerende impuls van de stichtende leden en sponsors, is vandaag uitgegroeid tot een innovatief kennisnetwerk van 'like minded people'.
In aanwezigheid van de heren Gouverneur Lodewijk De Witte, Burgemeester Louis Tobback, Vice-Rector | | |
| | | Charter 2010: Leuven - Knowledge Pearl | 29/10 | Compared to European standards, Leuven is a small city with a large international university and highly developed knowledge institutions and knowledge enterprises. The 'knowledge pearl' Leuven, as described on a recent international expert meeting, is a city in which knowledge is not only passed on but also produced and applied.
Transforming knowledge into social and economic value is high on our agenda. This objective however, is not always sufficiently acknowledged and the interaction | | |
| | | Quest for Growth invests 2 million euro in Clear2Pay | 28/10 | Leuven, October 26, 2004 - On October 26 Quest for Growth announced the investment of 2,000,000 euro in Clear2Pay NV/SA, a software vendor specializing in next generation payment solutions for financial institutions. Other investors in this round, which closed at ? 6.1 million, are current investors Technology Venture Partners (Australia); Koceram (Belgium) and Clear2Pay's management.
Clear2Pay was founded in 2001 with a vision to become a payment solutions provider that enables financial | | |
| | | Option reports strong third quarter results | 28/10 | Leuven, Belgium - 28 October 2004 - Option N.V. (EURONEXT Brussels: OPTI), the wireless technology company, today reported results for the three and nine-month periods ended September 30, 2004. The results are reported in Euro and are prepared in accordance with United States Generally Accepted Accounting Principles (US GAAP).
The highlights of the quarter included:
- Revenues for the third quarter of fiscal 2004 of EUR 23.1 million increased by 63% compared to the EUR 14.2 million generated | | |
| | | For first time, Option amongst Europe's 500 fastest growing companies | 22/10 | Leuven, Belgium - October 21st 2004 - OPTION (Euronext: OPTI), the wireless technology company, today announced that it has been listed amongst the fastest growing European companies included in the 2004 Europe's 500, an annual listing endorsed by Microsoft, Boston Consulting Group, PricewaterhouseCoopers and 3i and published by Europe's Entrepreneurs for Growth.
Option is one of 34 companies in Europe in the 'Communications & Electronics' sector who managed to qualify for Europe's 500.
| | |
| | | BIOTIM en WATERLEAU sluiten principeakkoord om hun milieuactiviteiten te bundelen | 18/10 | 
Brussel, 15 oktober 2004 - Biotim en Waterleau hebben een voorakkoord gesloten om hun milieuactiviteiten te bundelen. Dit voorakkoord zal voor het einde van het jaar bekrachtigd worden in een definitief akkoord met overdracht van aandelen.
Door het samenbrengen van know-how, technologieën, referenties, netwerk en geografische aanwezigheid wordt een milieubedrijf gecreëerd dat zich bij de Europese top mag rekenen en op het vlak van industriële anaërobe waterzuivering zelfs tot 's werelds | | |
| | | ICOS Vision Systems neemt 2D wafer inspectie activiteiten van Siemens AG over | 18/6 | | Heverlee, België, 10 juni 2004 - ICOS Vision Systems Corporation NV (Nasdaq en Euronext: IVIS), een wereldleider in visie- en inspectiesystemen voor de chipindustrie, maakte vandaag bekend dat het de wafer inspectie activiteiten van Siemens AG overneemt. Onder de overeenkomst neemt ICOS voor een totaal bedrag van 6,25 miljoen Euro cash alle rechten over op de Siemens twee dimensionale (2D) wafer inspectie technologie alsook alle activa van de wafer inspectie activiteiten van Siemens. De overname | | |
| | | Moldflow Corporation to resell Materialise's Magics | 17/5 | Decision Supports Growth of Mid-range Analysis Products
WAYLAND, MA & LEUVEN, BELGIUM - May 17, 2004 - Moldflow Corporation (NASDAQ:MFLO), and Materialise NV, today announced an agreement under which Moldflow will resell a customized version of Materialise's Magics stereolithography (STL) manipulation product designed specifically for the needs of Moldflow's customers in the plastics injection molding industry. Magics sets the standard for ease of use and efficiency for the cleanup and repair | | |
| | | Leuven.Inc welcomes BASF Antwerpen N.V. as a Sponsor Member | 30/4 | 
Leuven, April 30th, 2004 - The board of directors is pleased to announce that BASF Anwerpen N.V. has joined Leuven.Inc as a Sponsor Member for the next two years.
Today, Leuven.Inc is a horizontal multidisciplinary network platform and within this framework, a wide range of networking activities are organised, e.g. thematic events, modular seminars, visionary workshops, entrepreneurs café's, ... As such an innovative network frame is offered to members and participants, from which | | |
| | | Option announces private placement of 8.000.000 euro | 19/4 | Leuven, Belgium - 15 April, 2004 - Option NV (Euronext: OPTI) today announces that its board of directors has decided on April 15, 2004 to execute a private placement of new shares to a limited group of European institutional investors for a total amount of 8.000.000 euro through the issuance of new shares whereby the capital will be increased within the framework of the authorized capital with cancellation of preferential subscription rights of existing shareholders.
The issuance price per new | | |
| | | Diatos s.a. opens its R&D subsidiary Diatos n.v. in Belgium | 22/3 | - Biotech Fund Flanders (BFF) Makes Initial Investment in Diatos -
Paris, France & Leuven, Belgium - March 18, 2004 - Diatos S.A., a privately held biopharmaceutical company, announced today the expansion of its operations with the opening of a new research and development center in Leuven, Belgium. Last February the company announced a ?7 million round of financing, ?3 million of which came from the venture fund Biotech Fund Flanders (BFF), earmarked for the new R&D subsidiary in Flanders. | | |
| | | Option posts record year revenues and profits in 2003 | 18/2 | Leuven, Belgium - 17 February 2004 - Option N.V. (EURONEXT Brussels: OPTI), the wireless technology company, today reported results for the fourth quarter, and the full year ended December 31, 2003. The results are reported in Euro and are prepared in accordance with United States Generally Accepted Accounting Principles (US GAAP).
If you are interested, you can download the detailed report by clicking this link.
About Option - EURONEXT Brussels OPTI
Option is the wireless technology | | |
| | | ESA awards contract for the development of Galileo User Receivers to consortium led by Septentrio | 4/2 | | January 30, 2004, Leuven - ESA has awarded a contract for the C0 phase of the GALILEO Test User Segment to a consortium led by Septentrio, a leading European designer and manufacturer of satellite navigation receivers. Under this contract which is worth almost 3 million EURO, the consortium, which is composed of Septentrio, Rockwell Collins France, QinetiQ, Delft University of Technology, Ursa Minor, OMP, Deimos, SkySoft, Sagem and FDC, will start the work on the development of the first Galileo | | |
| | | CAPRICORN start kapitaalsronde voor nieuw IMEC Technology Fund (ITF) | 4/2 | Leuven, 04/02/2004 - Capricorn Venture Partners en het Leuvense onderzoekscentrum IMEC zullen nauw samenwerken om nieuwe IMEC spin-off initiatieven financieel te steunen via start- en zaaikapitaal. Door dit samenwerkingsakkoord is Capricorn Venture Partners gemandateerd om de nodige financiering voor de oprichting van het zaaikapitaalfonds ITF te werven.
Capricorn Venture Partners streeft ernaar om in het kader van de oprichting van ITF 40-60 miljoen euro te werven bij lokale en | | |
| | | Press release: TiGenix raises EUR 12 million in first round financing | 2/10 | LEUVEN (BELGIUM), October 1 - TiGenix, a Belgium based biomedical company, focusing on the functional repair of damaged and diseased musculoskeletal tissues, announces that it has closed a EUR 12 million financing round with leading European venture capital funds.
The lead investor in the round is ING Private Equity, with the funds advised by Capricorn Venture Partners as co-lead. The funds advised by Auriga Partners and Fagus also participate to the round. Through the conversion of an | | |
| | | HyperTrust haalt 1,3 miljoen euro kapitaal op en mikt op Nederland | 22/7 | | Leuven, 15 juli 2003 - HyperTrust, de Leuvense aanbieder van actieve opslagtoepassingen via internet, heeft ruim 1,3 miljoen euro vers kapitaal opgehaald. De middelen werden ter beschikking gesteld door de bestaande aandeelhouders, waaronder een consortium privé-investeerders, de KU Leuven, IT Partners en Advalvas Group, en een aantal nieuwe privé-investeerders. Tegelijk wordt de heer Joop Van Aard voorgedragen als lid van de raad van bestuur van HyperTrust, die wordt voorgezeten door Prof. Dr. | | |
| | | Materialise realiseert belangrijke kapitaalsverhoging van Eur 10 m. | 10/10 | Het Leuvense hi-tech bedrijf Materialise NV heeft een strategische kapitaalsverhoging van
10 miljoen Euro afgesloten met Belgische en Japanse partners.
Materialise heeft zich vanaf haar oprichting steeds kunnen profileren als een winstgevend
groeibedrijf. Ook in tijden van een slechtere economische situatie kent het bedrijf een gestage en
rendabele groei. Om deze expansie op wereldschaal te kunnen blijven voortzetten werden vanuit
strategisch en financieel oogpunt investeerders | | |
| | | Metris: the acquisition of Paraform | 13/9 | Leuven, Belgium. - September 11, 2002 - Metris International Holding n.v. (Metris) , a leader in quality control, reverse engineering and 3D digitizing for the design and manufacturing community, today announced the acquisition of Paraform, Inc.
The Paraform acquisition adds a wealth of complementary products and technologies covering a range of applications including: reverse engineering, polygonal modeling, design for manufacturability, rapid surfacing, and others. The combined companies | | |
| | | Agfa-Gevaert Group's Half Year Results 2002 | 22/8 | Turnaround confirmed:
· Return on sales over 10 percent
· Net profit nearly doubled
· Working capital target exceeded
Press Release
Mortsel, August 22nd, 2002
After two quarters in 2002, Agfa's sales reached 2,378 million Euros. The Group's Operating result before restructuring and net nonrecurring expenses increased 51 percent compared to the same period of 2001. Moreover, net profit nearly doubled to 59 million Euros and the target to reduce working capital by 500 million Euros | | |
| | | Septentrio haalt 1,5 miljoen euro op | 20/8 | | Septentrio, de Leuvense ontwikkelaar en producent van ontvangers voor navigatie per satelliet, rondde in juli een kapitaalsverhoging af. De bestaande aandeelhouders, waaronder het micro-elektronicacentrum IMEC, risicokapitaalfondsen IT Partners en Creon en privé-investeerders 'van het eerste uur', brachten 1,5 miljoen euro bijeen waardoor het kapitaal nu 4,5 miljoen euro bedraagt. Het verse geld is nodig voor de commercialisatie en de start van de productie van de satellietontvangers die in de | | |
| | | Gemma Frisius 2 investeert in QMedit | 30/7 | Spin-off KU Leuven haalt 750.000 euro op
Het durfkapitaalfonds Gemma Frisius 2 heeft zijn eerste investering afgerond. Het gaat om QMedit, het resultaat van een fusie tussen Leuvense technologiebedrijven. Gemma investeert 750.000 euro, goed voor een minderheidsbelang. QMedit is gespecialiseerd in softwaretoepassingen voor netwerken van ziekenhuizen, specialisten en huisartsen die werken volgens zorgpaden.
Gemma Frisius 2 werd eind mei opgericht door de Leuvense universiteit, KBC | | |
| | | Gemma Frisius Fonds II launched | 16/7 | | On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a venture capital fund providing seed capital and start-up capital to spin-off companies intending to commercialize knowledge and research developed at K.U.Leuven. Following the success of the first edition of the Fund, the three partners - Fortis Private Equity, KBC Investco and K.U.Leuven Research & Development - unanimously decided to extend this unique form of | | |
| | | HyperTrust Increases Capital By 1,5 Million EUR | 16/5 | LOUVAIN (Belgium), May 15, 2002 - HyperTrust, Europe's first Trust Application Service Provider today announces a capital increase of 1,5 million Euros. The Catholic University of Louvain is among the new investors. The existing shareholders confirm their confidence in the company. Paul Carpentier - co-founder of FilePool - joins the HyperTrust management team.
A group of private investors, previously shareholders in FilePool, a Belgian technology company, subscribes to a capital increase | | |
| | | Technologiebedrijf Hypertrust haalt 1,5 miljoen euro op | 16/5 | Rector Oosterlinck van K.U.Leuven wordt voorzitter
Het Leuvense technologiebedrijf Hypertrust haalt 1,5 miljoen euro vers kapitaal op bij de risico-investeerder IT Partners, de Leuvense universiteit en een reeks particuliere investeerders. De rector van de K.U.Leuven, André Oosterlinck, wordt voorzitter. Hypertrust levert oplossingen om internetverkeer rechtsgeldig te maken. Het verse geld dient voor de Europese uitbreiding. | | |
| | | Leuvense spin-off Metris haalt 5 miljoen euro op | 16/5 | Fortis, Gimv, KBC en Dexia investeren samen met Japanese groepen.
Het Leuvense technologiebedrijf Metris, spin-off van de K.U.leuven haalt 5 miljoen euro op via private plaatsing. Meer dan de helft van dat bedrag wordt geïnjecteerd door de Japanese investeringsvennootschappen NIF Ventures en Sumitomo Corporation. Metris, dat nog geen zeven jaar bestaat, levert een unieke soort software voor kwaliteitscontrole in de auto- en luchtvaartindustrie. | | |
| | | The development of Campus Remy has started! | 15/4 | The construction works for the first 10.500 m² building of Campus Remy have taken off. After long administrative problems, the developer was finally able to start the construction of this new office park in the Leuven region.
This unique new business park will be erected in a green environment between the Leuven canal and the station of Wijgmaal on the site of the well-known 1855 Remy factory. A modern business park consisting of newly built offices as well as renovated industrial loft style | | |
| | | | | Finally office space available in the high tech office park Greenhill Campus Haasrode! | 10/2 | During the construction of Greenhill Campus in 1999-2000 all buildings where pre-let before completion, starting with Eunet, followed by companies such as Lant, IT Masters, Utimaco Safeware, Evosoft, etc and ending with the Regus business centre. Only the Leasureplanet bankruptcy allowed Newmonday.com to fill in a large floor.
However, in 2002, we can again offer large surfaces!
As of March 2002, due to an occupants reorganisation, 1.780 m² offices in building E will be available. These | | |
| | | DSP Valley already attracts four major investments in first half of 2001 | 6/9 | DSP Valley, center of excellence in fabless DSP systems design, acts as a magnet in attracting investments in high-tech in Flanders, Belgium
In the first half of 2001, the highly specialized competencies and expertise in fabless design of DSP systems, available within the research organizations and industrial companies in DSP Valley, already attracted four investments. Investments were made by Resonext Communications, Wind Rivers Systems, Agilent Technologies and Philips Semiconductors.
In | | |
| | | CAPRICORN & NEO GROUP JOIN FORCES TO BECOME SIGNIFICANT PLAYER IN EUROPEAN VENTURE CAPITAL | 8/5 | Capricorn Venture Fund II to focus on Technology in the broadest sense
Leuven, May 8th 2001.
Capricorn Venture Partners today announced it is starting to raise in excess of ?100M for its Capricorn Venture Fund II, primarily targeting Belgian and international institutional investors. The new venture capital fund will make investments on a pan-European basis in growth companies active in information technology, the medical and health care sector, as well as new materials.
The difficulties | | |
| | | Gemma Frisius Investment Forum. | 11/12 | More then 220 enthusiastic participants were registered for the GFF seminar that took place on Nov 30; Next to key note speeches on trends in the financing and the valuation of spin-off companies, some 12 spin-offs had the opportunity to present their company.
Plenty of informal contacts were possible around a small exhibition corner. | | |
| | | AdValvas Group and IT-Partners Participate in HyperTrust | 17/11 | Leuven, November 17th, 2000. HyperTrust, Europe's first Trust Application Service Provider (ASP), closed its first round of financing, raising EUR 1,24 million from AdValvas Group and IT-Partners.
The capital increase will enable the young company, headquartered in Leuven, to develop its products with the support of two important businesses. AdValvas Group, a leading Internet business generator on the Belgian market, and IT-Partners will strategically and commercially assist HyperTrust.
| | |
| | | Keep us updated with your latest news! | 16/8 | All company members of Leuven.Inc can have their newsflashes on the website.
To do this, login and select My Press Releases from the left-hand menu bar displayed on your home page section within this website. | | |
| | | IMEC Incubation Fund to stimulate the foundation of spin-offs | 9/9 | IMEC to provide financial and technological environment for future high-tech companies based on IMEC technology.
Leuven, Belgium -- October 16, 2001 --- IMEC, Europe's leading independent research and development center in microelectronics and information and communication technologies (ICT), has announced the creation of its Incubation Fund to support the launch phase of new spin-off companies.
One of IMEC's strategic objectives is to support the local industry in Flanders (Belgium) by | | |
| |
|
|
|
|
|
|
|
Contact